Deval Modi

Deval Modi is a Clinical Research Associate II at Corcept Therapeutics, with extensive experience in clinical research roles across multiple organizations, including Talis Biomedical Corporation and Roche. At Talis, Deval led pivotal COVID-19 studies, securing EUA approval for the Talis One Assay and refining clinical trial processes. Previous experience includes managing various oncology studies, coordinating complex clinical trials at Care Access Research, and contributing to veteran healthcare research at the U.S. Department of Veterans Affairs. Deval’s foundational clinical training includes a Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) from The Maharaja Sayajirao University of Baroda and an Administrator in Training degree from Virgil Rehabilitation & Skilled Nursing Center.